Meg Alexander

Mimecast Pardot Microsoft Office 365 Google Cloud Hosting BugHerd WordPress.org Google Tag Manager YouTube reCAPTCHA Google Analytics Mobile Friendly Nginx Render Remote Circle

biotechnology: pharmaceutical preparations health care biotechnology research epilepsy seizure neurological disorders biopharmaceuticals small molecule therapies gaba aminotransferase inhibitor rock2 inhibitor kcc2 activator targeted therapies first-in-class best-in-class clinical development drug pipeline patient advocacy treatment-resistant epilepsy therapeutic area neurodevelopmental conditions neuropsychiatric disorders rare diseases oral medication intravenous administration patient safety clinical trials phase 1 phase 2 pharmacokinetics seizure reduction adaptive trial design neuroscience innovative treatments safety & tolerability patient experience biotechnology collaborative partnerships investor relations scientific strategy research development clinical assets medical breakthroughs treatment options healthcare innovation therapeutic mechanisms neuron excitability cns disorders seizure management healthcare outcomes research partnerships patient communities scientific collaborations drug discovery seizure disorders patient-centric approach innovative medicines neuronal hyperexcitability treatment-resistant seizures cerebral cavernous malformations neurovascular conditions neuro-inflammatory conditions drug development quality of life unmet medical needs kcc2 activators rock2 inhibitors therapeutic pipeline patient insights partnerships collaborations neurotherapeutics pediatric epilepsy adult epilepsy anti-psychotic effects anticonvulsant effects next-generation therapies patient outcomes scientific research community engagement health wellness & fitness hospital & health care